麦门冬汤合苇茎汤抑制小鼠Lewis肺癌生长的体内实验研究  被引量:10

Study of JIN Formula on inhibiting the Lewis Lung Carcinoma in vivo

在线阅读下载全文

作  者:熊飞[1] 周宗剑[2] 姜淼[1] 陈美娟[1] 黄震洲[1] 唐于平[3] 段金廒[3] 詹臻[1] 蒋明[4] 张旭[1,3] 

机构地区:[1]南京中医药大学基础医学院,江苏南京210046 [2]山西省临汾市人民医院消化科,山西临汾041000 [3]江苏省方剂研究重点实验室,江苏南京210046 [4]香港浸会大学中医药学院,香港

出  处:《南京中医药大学学报》2011年第2期144-147,共4页Journal of Nanjing University of Traditional Chinese Medicine

基  金:国家科技部“十一五”科技支撑计划重点项目(2006BAI11B08-01)

摘  要:目的研究麦门冬汤合苇茎汤(简称金方/JIN)对Lewis肺癌小鼠移植瘤的抑制作用并初步探讨药物作用机制。方法皮下注射LLC(Lewis lung carcinoma,Lewis肺癌细胞)于C57/BL6小鼠右腋下,观察小鼠生存期、抑瘤率、胸腺指数和肿瘤组织EGFR/Raf/MEK的表达。结果金方可以显著延长小鼠的生存时间,与对照组相比有显著性差异(P<0.01),金方、DDP组对荷瘤小鼠的抑瘤率分别为35%、89%,金方组胸腺指数明显升高,DDP组胸腺指数明显下降,金方、DDP组的EGFR表达均下降(P>0.05,P<0.01),而各组Raf和MEK表达无显著性差异。结论金方可以显著延长荷瘤小鼠的生存期,有一定的抑制肿瘤增长和增强免疫能力的作用,其机制可能与其下调肿瘤组织中EGFR的表达进而影响其下游信号通路的传导相关。OBJECTIVE To investigate the effect of JIN Fang(Maimendong Decoction and Weijing Decoction,are ancient formulae from Golden Chamber,and abbreviated as JIN Fang) on inhibiting Lewis xenografted tumor and the mechanism.METHODS Lewis lung carcinoma cells were inoculated subcutaneously into right axillary of C57 BL /6 mice,and then the following data were observed:the mice survival time,tumor inhibiting rate,thymus index,and the expression of EGFR/Raf/MEK in the tumor tissue.RESULTS JIN could significantly prolong the survival time,(compared with the control group,P0.01),and the tumor inhibiting rate of JIN and DDP were 35%,89% respectively.JIN significantly increased the thymus index,while DDP group significantly decreased the thymus index.The expression of EGFR in the tissue of mice tumor was reduced in JIN and DDP groups(P0.05,P0.01);the expression Raf and MEK in different groups had no notable difference.CONCLUSION JIN can not only significantly prolong the survival time of the mice,but also has certain effect on inhibiting tumor growth and enhancing immunity.This may be due to down-regulating the expression of EGFR in tumor tissue and its downstream signal transduction pathway.

关 键 词:麦门冬汤合苇茎汤 LEWIS肺癌 免疫 信号通路 

分 类 号:R285[医药卫生—中药学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象